MBrace Therapeutics Funding & Investors
MBrace Therapeutics is a privately held biopharmaceutical business dedicated to improving cancer patients' quality of life by developing antibody-drug conjugates (ADCs) against novel oncology targets.
mbracetrx.comTotal Amount Raised: $110,000,000
MBrace Therapeutics Funding Rounds
Series B
$85,000,000
Series B Investors
Avidity PartnersVenrockAlta PartnersTPGCowenSeries A
$25,000,000
Series A Investors
VenrockAlta Partners
Funding info provided by Diffbot.